How much profit has DocMorris made this year?
DocMorris has made -102.41 M CHF this year.
DocMorris Net Income 2024
DocMorris Net Income
-102.41 M CHF
Ticker
DOCM.SW
ISIN
CH0042615283
WKN
A0Q6J0
In 2024, DocMorris's profit amounted to -102.41 M CHF, a -224.47% increase from the 82.28 M CHF profit recorded in the previous year.
The DocMorris Net Income history
| YEAR | NET INCOME (undefined CHF) |
|---|---|
| 2029e | - |
| 2028e | 124.52 |
| 2027e | 92.98 |
| 2026e | -16.9 |
| 2025e | -71.04 |
| 2024e | -102.41 |
| 2023 | 82.28 |
| 2022 | -171.1 |
| 2021 | -225.7 |
| 2020 | -135.7 |
| 2019 | -52.4 |
| 2018 | -39 |
| 2017 | -36.2 |
| 2016 | -12.8 |
| 2015 | 3.4 |
| 2014 | 7.2 |
| 2013 | -15.5 |
| 2012 | 6.1 |
DocMorris Revenue, EBIT, Net Income CH0042615283 · A0Q6J0
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into DocMorris, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DocMorris from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DocMorris’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of DocMorris. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into DocMorris’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing DocMorris’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DocMorris’s growth potential.
DocMorris Revenue, EBIT and net profit per share
| Date | DocMorris Revenue | DocMorris EBIT | DocMorris Net Income |
|---|---|---|---|
| 2029e | 3.12 B undefined | 0 undefined | 0 undefined |
| 2028e | 2.83 B undefined | 128.85 M undefined | 124.52 M undefined |
| 2027e | 2.52 B undefined | 95.54 M undefined | 92.98 M undefined |
| 2026e | 1.63 B undefined | -2.64 M undefined | -16.9 M undefined |
| 2025e | 1.32 B undefined | -49.95 M undefined | -71.04 M undefined |
| 2024e | 1.06 B undefined | -90.31 M undefined | -102.41 M undefined |
| 2023 | 969.46 M undefined | -81.81 M undefined | 82.28 M undefined |
| 2022 | 1.61 B undefined | -133.9 M undefined | -171.1 M undefined |
| 2021 | 1.73 B undefined | -189.8 M undefined | -225.7 M undefined |
| 2020 | 1.48 B undefined | -109.3 M undefined | -135.7 M undefined |
| 2019 | 1.36 B undefined | -63.2 M undefined | -52.4 M undefined |
| 2018 | 1.21 B undefined | -31.4 M undefined | -39 M undefined |
| 2017 | 982.9 M undefined | -32.2 M undefined | -36.2 M undefined |
| 2016 | 879.5 M undefined | -7 M undefined | -12.8 M undefined |
| 2015 | 834.4 M undefined | 8.4 M undefined | 3.4 M undefined |
| 2014 | 915.6 M undefined | 8.2 M undefined | 7.2 M undefined |
| 2013 | 910.6 M undefined | -3.2 M undefined | -15.5 M undefined |
| 2012 | 523.3 M undefined | 2.6 M undefined | 6.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2012 | 523.3 M CHF | 2.6 M CHF | 6.1 M CHF |
| 2013 | 910.6 M CHF | -3.2 M CHF | -15.5 M CHF |
| 2014 | 915.6 M CHF | 8.2 M CHF | 7.2 M CHF |
| 2015 | 834.4 M CHF | 8.4 M CHF | 3.4 M CHF |
| 2016 | 879.5 M CHF | -7 M CHF | -12.8 M CHF |
| 2017 | 982.9 M CHF | -32.2 M CHF | -36.2 M CHF |
| 2018 | 1.21 B CHF | -31.4 M CHF | -39 M CHF |
| 2019 | 1.36 B CHF | -63.2 M CHF | -52.4 M CHF |
| 2020 | 1.48 B CHF | -109.3 M CHF | -135.7 M CHF |
| 2021 | 1.73 B CHF | -189.8 M CHF | -225.7 M CHF |
| 2022 | 1.61 B CHF | -133.9 M CHF | -171.1 M CHF |
| 2023 | 969.46 M CHF | -81.81 M CHF | 82.28 M CHF |
| 2024e | 1.06 B CHF | -90.31 M CHF | -102.41 M CHF |
| 2025e | 1.32 B CHF | -49.95 M CHF | -71.04 M CHF |
| 2026e | 1.63 B CHF | -2.64 M CHF | -16.9 M CHF |
| 2027e | 2.52 B CHF | 95.54 M CHF | 92.98 M CHF |
| 2028e | 2.83 B CHF | 128.85 M CHF | 124.52 M CHF |
| 2029e | 3.12 B CHF | 0 CHF | 0 CHF |
DocMorris stock margins CH0042615283 · A0Q6J0
The DocMorris margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocMorris. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocMorris.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the DocMorris's sales revenue. A higher gross margin percentage indicates that the DocMorris retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the DocMorris's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the DocMorris's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DocMorris's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DocMorris. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DocMorris's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
DocMorris Margin History
| DocMorris Gross margin | DocMorris Profit margin | DocMorris EBIT margin | DocMorris Profit margin |
|---|---|---|---|
| 2029e | 20.98 % | 0 % | 0 % |
| 2028e | 20.98 % | 4.56 % | 4.4 % |
| 2027e | 20.98 % | 3.8 % | 3.7 % |
| 2026e | 20.98 % | -0.16 % | -1.04 % |
| 2025e | 20.98 % | -3.8 % | -5.4 % |
| 2024e | 20.98 % | -8.52 % | -9.66 % |
| 2023 | 20.98 % | -8.44 % | 8.49 % |
| 2022 | 15.27 % | -8.33 % | -10.64 % |
| 2021 | 15.41 % | -10.99 % | -13.07 % |
| 2020 | 16.86 % | -7.4 % | -9.19 % |
| 2019 | 15.4 % | -4.66 % | -3.87 % |
| 2018 | 15.86 % | -2.6 % | -3.23 % |
| 2017 | 15.03 % | -3.28 % | -3.68 % |
| 2016 | 15.02 % | -0.8 % | -1.46 % |
| 2015 | 15.06 % | 1.01 % | 0.41 % |
| 2014 | 15.26 % | 0.9 % | 0.79 % |
| 2013 | 15.21 % | -0.35 % | -1.7 % |
| 2012 | 14.37 % | 0.5 % | 1.17 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2012 | 14.37 % | 0.5 % | 1.17 % |
| 2013 | 15.21 % | -0.35 % | -1.7 % |
| 2014 | 15.26 % | 0.9 % | 0.79 % |
| 2015 | 15.06 % | 1.01 % | 0.41 % |
| 2016 | 15.02 % | -0.8 % | -1.46 % |
| 2017 | 15.03 % | -3.28 % | -3.68 % |
| 2018 | 15.86 % | -2.6 % | -3.23 % |
| 2019 | 15.4 % | -4.66 % | -3.87 % |
| 2020 | 16.86 % | -7.4 % | -9.19 % |
| 2021 | 15.41 % | -10.99 % | -13.07 % |
| 2022 | 15.27 % | -8.33 % | -10.64 % |
| 2023 | 20.98 % | -8.44 % | 8.49 % |
| 2024e | 20.98 % | -8.52 % | -9.66 % |
| 2025e | 20.98 % | -3.8 % | -5.4 % |
| 2026e | 20.98 % | -0.16 % | -1.04 % |
| 2027e | 20.98 % | 3.8 % | 3.7 % |
| 2028e | 20.98 % | 4.56 % | 4.4 % |
| 2029e | 20.98 % | 0 % | 0 % |
DocMorris Aktienanalyse
What does DocMorris do?
The Zur Rose Group AG is a Swiss company that specializes in online trading of medications and health products. The company was founded in 1993 in Steckborn and initially focused on the mail order of homeopathic medicines. In 1997, the online shop www.zurrose.de was opened and the company began to expand its distribution to non-homeopathic medicines. The business model of the Zur Rose Group AG is based on a three-pillar model, encompassing e-commerce, wholesale, and healthcare. In the e-commerce sector, the company operates online pharmacies in various countries including Germany, France, Austria, the Netherlands, and Switzerland. In the wholesale sector, the company supplies pharmacies and hospitals with medicines and medical products. In the healthcare sector, the company offers various services in healthcare, from the production of medicines to the processing of prescriptions. The Zur Rose Group AG offers a wide range of products and services including prescription and over-the-counter medications, natural remedies, cosmetic products, dietary supplements, and medical devices. The company aims to provide its customers with a comprehensive selection of high-quality products and works closely with its suppliers to ensure that all products meet the highest quality standards. In the e-commerce sector, the company operates various online pharmacies, including Zur Rose Apotheke in Germany, Zur Rose Apotheke in Austria, and Doctipharma in France. These online pharmacies offer a wide range of medications and health products that can be ordered online and conveniently delivered to customers' homes. The online pharmacies are open 24/7, allowing customers to quickly and easily order their needed medications. In the wholesale sector, the company offers a wide range of pharmaceutical products and medical devices to pharmacies and hospitals. The company works closely with its suppliers to ensure that all products meet the highest quality standards. Additionally, the company also provides a fast and reliable delivery service to ensure that its customers are always provided with the needed medications and medical products. In the healthcare sector, the company offers various services in healthcare, including digitalization solutions for pharmacies, manufacturing of medications, and processing of prescriptions. The company works closely with its customers to offer tailored solutions that meet their individual requirements. Over the years, the Zur Rose Group AG has become a leading provider in the online trading of medications and health products. The company has distinguished itself through its wide product range, fast and reliable delivery service, and excellent customer service. Additionally, the company has also invested in the development of new technologies to ensure that it can always offer its customers the best products and services. Overall, the Zur Rose Group AG is an innovative company built on a long history in healthcare. The company strives to offer its customers a wide range of high-quality products and services and has established itself as a leading provider in the online trading of medications and health products. DocMorris ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding DocMorris's Profit Margins
The profit margins of DocMorris represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of DocMorris's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating DocMorris's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
DocMorris's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When DocMorris’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about DocMorris stock
How has the profit developed compared to last year?
The profit has increased by -224.47% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does DocMorris publish its earnings?
DocMorris publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of DocMorris?
The profits of DocMorris are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of DocMorris?
You can learn more about the earnings of DocMorris by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does DocMorris pay?
Over the past 12 months, DocMorris paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DocMorris is expected to pay a dividend of 0 CHF.
What is the dividend yield of DocMorris?
The current dividend yield of DocMorris is .
When does DocMorris pay dividends?
DocMorris pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DocMorris?
DocMorris paid dividends every year for the past 0 years.
What is the dividend of DocMorris?
For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.
In which sector is DocMorris located?
DocMorris is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von DocMorris kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DocMorris from 11/25/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.
When did DocMorris pay the last dividend?
The last dividend was paid out on 11/25/2024.
What was the dividend of DocMorris in the year 2023?
In the year 2023, DocMorris distributed 0 CHF as dividends.
In which currency does DocMorris pay out the dividend?
The dividends of DocMorris are distributed in CHF.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DocMorris
Our stock analysis for DocMorris Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocMorris Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.